The CT genotype might evidently enhanced risk of CC, GC, colon cancer, brain tumor and esophageal squamous cell carcinoma, suggesting PD- 1.5 variant as a risk factor in some cancers. This evidence concerns the gene RPL17 and malignant colon neoplasm.